A public ledger of independent results.
Vendors who participate in our public-listing programme have their results published here — pass or fail, with their consent. We also run an independent blind-testing programme that purchases samples directly and publishes the result regardless.
Vendors who pass our tests can show it.
Manufacturers and distributors who agree to publish every result — pass or fail — for a 12-month period receive Verified-by-CRAFA status and a public dashboard at crafa.online/v/<vendor>. The badge can be displayed on their store; the underlying data is hosted by us, not them.
It is the only meaningful trust signal in this market. We don't sell it. It's earned, sample by sample.
Anonymous purchasing, public reporting.
Once per month CRAFA spends its own funds purchasing peptide and SARM samples from vendors marketed to retail buyers. We order under a clean shipping address with no laboratory association. The compound is tested under the same conditions any other client sample would be — and the result is published here whether the vendor consented or not.
The programme is not adversarial. It exists because the only way to keep a market honest is to know that someone is checking.
Next round scheduled — Q2 2026